Kelly Moynihan, Ph.D.

Kelly D. Moynihan received a B.S. degree in biomedical engineering from the University of Texas followed by a Ph.D. in biological engineering from MIT in the lab of Darrell Irvine, where she was a Hertz Foundation Fellow, NSF Fellow, and Siebel Scholar. Kelly then worked in biotech company creation at Third Rock Ventures, where she contributed to the formation and launch of multiple immunology-focused biotech startups, including Celsius Therapeutics, Abata Therapeutics, and Asher Biotherapeutics. Kelly now works as a Senior Director and Program Team Leader for AB248 at Asher Biotherapeutics, a clinical-stage South San Francisco-based biotechnology company.